96 related articles for article (PubMed ID: 14514389)
21. [Puerperal inhibition of lactation with metergoline or bromocriptine].
Fischer T; Streitmatter A; Gerede A; Frauendorf A; Krause M; Feige A
Z Geburtshilfe Neonatol; 1995; 199(3):111-5. PubMed ID: 7553254
[TBL] [Abstract][Full Text] [Related]
22. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
[TBL] [Abstract][Full Text] [Related]
23. A trial of contraceptive methods in women with systemic lupus erythematosus.
Sánchez-Guerrero J; Uribe AG; Jiménez-Santana L; Mestanza-Peralta M; Lara-Reyes P; Seuc AH; Cravioto MD
N Engl J Med; 2005 Dec; 353(24):2539-49. PubMed ID: 16354890
[TBL] [Abstract][Full Text] [Related]
24. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
Petri MA; Lahita RG; Van Vollenhoven RF; Merrill JT; Schiff M; Ginzler EM; Strand V; Kunz A; Gorelick KJ; Schwartz KE;
Arthritis Rheum; 2002 Jul; 46(7):1820-9. PubMed ID: 12124866
[TBL] [Abstract][Full Text] [Related]
25. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
[TBL] [Abstract][Full Text] [Related]
26. Oral contraceptive therapy and systemic lupus erythematosus.
Travers RL; Hughes GR
J Rheumatol; 1978; 5(4):448-51. PubMed ID: 310887
[TBL] [Abstract][Full Text] [Related]
27. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
[TBL] [Abstract][Full Text] [Related]
28. Mood states and disease activity in patients with systemic lupus erythematosus treated with bromocriptine.
Walker SE; Smarr KL; Parker JC; Weidensaul DN; Nelson W; McMurray RW
Lupus; 2000; 9(7):527-33. PubMed ID: 11035419
[TBL] [Abstract][Full Text] [Related]
29. Prolactin and systemic lupus erythematosus.
McMurray RW
Ann Med Interne (Paris); 1996; 147(4):253-8. PubMed ID: 8952744
[TBL] [Abstract][Full Text] [Related]
30. Prolactin as a modulator of B cell function: implications for SLE.
Peeva E; Venkatesh J; Michael D; Diamond B
Biomed Pharmacother; 2004 Jun; 58(5):310-9. PubMed ID: 15194167
[TBL] [Abstract][Full Text] [Related]
31. Flares in lupus: Outcome Assessment Trial (FLOAT), a comparison between oral methylprednisolone and intramuscular triamcinolone.
Danowski A; Magder L; Petri M
J Rheumatol; 2006 Jan; 33(1):57-60. PubMed ID: 16395750
[TBL] [Abstract][Full Text] [Related]
32. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus.
Walker SE; McMurray RW; Houri JM; Allen SH; Keisler D; Sharp GC; Schlechte JA
Ann N Y Acad Sci; 1998 May; 840():762-72. PubMed ID: 9629303
[TBL] [Abstract][Full Text] [Related]
33. Treatment of systemic lupus erythematosus with bromocriptine.
Walker SE
Lupus; 2001; 10(3):197-202. PubMed ID: 11315352
[TBL] [Abstract][Full Text] [Related]
34. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus.
Karlson EW; Liang MH; Eaton H; Huang J; Fitzgerald L; Rogers MP; Daltroy LH
Arthritis Rheum; 2004 Jun; 50(6):1832-41. PubMed ID: 15188360
[TBL] [Abstract][Full Text] [Related]
35. Bromocriptine in rheumatic and autoimmune diseases.
McMurray RW
Semin Arthritis Rheum; 2001 Aug; 31(1):21-32. PubMed ID: 11503136
[TBL] [Abstract][Full Text] [Related]
36. Bromocriptine in an injectable retard form for puerperal lactation suppression: comparison with Estandron prolongatum.
Defoort P; Thiery M; Baele G; Clement D; Dhont M
Obstet Gynecol; 1987 Dec; 70(6):866-9. PubMed ID: 3684122
[TBL] [Abstract][Full Text] [Related]
37. Bromocriptine therapy of luteal insufficiency accompanied with hyperprolactinemia in the follicular phase.
Kano T; Nishikawa K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):975-80. PubMed ID: 6875348
[TBL] [Abstract][Full Text] [Related]
38. Standard and higher doses of bromocriptine for severe chronic portal-systemic encephalopathy.
Uribe M; García-Ramos G; Ramos M; Valverde C; Márquez MA; Farca A; Guevara L
Am J Gastroenterol; 1983 Aug; 78(8):517-22. PubMed ID: 6881119
[TBL] [Abstract][Full Text] [Related]
39. Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital.
Foocharoen C; Nanagara R; Salang L; Suwannaroj S; Mahakkanukrauh A
J Med Assoc Thai; 2009 Feb; 92(2):167-74. PubMed ID: 19253790
[TBL] [Abstract][Full Text] [Related]
40. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease.
McMurray RW; Allen SH; Braun AL; Rodriguez F; Walker SE
J Rheumatol; 1994 May; 21(5):843-50. PubMed ID: 8064724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
